News Author: Susan London Publish date: January 6, 2016
Key clinical point: In patients with castration-resistant metastatic prostate cancer, CTC heterogeneity affects the response to hormonal therapy b...
News Author: Susan London Publish date: January 5, 2016
Key clinical point: Cabozantinib appears more efficacious than does everolimus for a wide range of patients.
Major finding: Progression-free survi...
News Author: Susan London Publish date: January 5, 2016
Key clinical point: Regular aspirin use may reduce the risk of developing advanced prostate cancer and dying from the disease.
Major finding: Men ...
News Author: Susan London Publish date: January 5, 2016
Key clinical point: Receipt of radiation therapy had little effect on risks among nonsmokers, but increased the risk of lung cancer and cardiac mo...
News Author: Susan London Publish date: January 4, 2016
Key clinical point: BRCA1/2 mutation in triple-negative breast cancer is predictive but only weakly prognostic.
Major finding: Patients with a BRC...
News Author: Susan London Publish date: January 4, 2016
Key clinical point: Pembrolizumab appears safe and modestly active for treatment of ER-positive, HER2-negative advanced breast cancer that express...
News Author: Susan London Publish date: December 30, 2015
A new stem cell transplant approach for patients with type 1 diabetes that addressed both underlying autoimmunity and pancreatic beta-cell repair and ...
News Author: Susan London Publish date: December 29, 2015
Key clinical point: Buparlisib modestly improves progression-free survival among women with progressive hormone receptor–positive, HER2-nega...
News Author: Susan London Publish date: December 28, 2015
Key clinical point: A high level of APOBEC3B expression in estrogen receptor–positive breast cancer is a marker for tamoxifen resistance.
Ma...
News Author: Susan London Publish date: December 23, 2015
Key clinical point: Compared with BMI, disease duration and control and type of procedure are better predictors of diabetes remission and control ...
News Author: Susan London Publish date: December 19, 2015
Key clinical point: Breaking up prolonged sitting with short bouts of either standing or walking blunts the postprandial metabolic response in wom...
News Author: Susan London Publish date: December 19, 2015
Key clinical point: Breaking up prolonged sitting with short bouts of either standing or walking blunts the postprandial metabolic response in wom...
News Author: Susan London Publish date: December 18, 2015
Key clinical point: Women with estrogen receptor–positive advanced breast cancer who have an ESR1 mutation are at increased risk for death.
...
News Author: Susan London Publish date: December 18, 2015
News Author: Susan London Publish date: December 17, 2015
Key clinical point: T-DM1 is safe and efficacious for treating heavily pretreated HER2-positive breast cancer.
Major finding: The median overall s...
